AMA Group Ltd (AMA)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.480 |
|---|---|
| 52-week range | 0.411 – 1.040 |
| Return, 1 month / 3 months | −2.0% / +10.1% |
| Return, 1 year / 3 years | −47.9% / +6.2% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 55.8% |
| Worst drawdown (1 year) | -58.5% |
| Average daily value traded | 0.14M AUD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AMA Group is an Australian company that provides collision repair and automotive aftercare services. It operates a network of panel and paint workshops that repair damaged vehicles, serving motorists, insurers and fleet operators across Australia and New Zealand. The company also supplies automotive parts and accessories through related businesses, supporting both its own repair network and outside customers. Its operations centre on vehicle body repair and the supply of components needed to return cars to the road after accidents.
AMA Group Ltd trades under the code AMA on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AMA Group Ltd (AMA) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.480 on 20 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 983 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 47.9% and over the last three months it rose 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.7% | ||
| From 52-week high | -51.6% | ||
| Momentum | 50 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 10.1% | ||
| 6-month return | -16.5% | ||
| 12-month return, skipping the last month | -46.8% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 55.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.5% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.14M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 5 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | −2.0% |
| 3 months | +10.1% |
| 6 months | −16.5% |
| 1 year | −47.9% |
| 3 years | +6.2% |
| 5 years | −86.8% |
Signals
| 50-day / 200-day average | 0.490 / 0.544 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.022 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | AUD 0.0050 |
| 12 Sep 2019 | AUD 0.0171 |
| 14 Mar 2019 | AUD 0.0038 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.